4th Quarter - Report

FABIANI & COMPANY for ARCA BIOPHARMA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Federal funding to support development of biopharmaceutical products to treat military and civilian populations

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
MELISSA DUPREE —
WENDY SHELTON —
JEFFREY STUART WIENER —

Contacted: Defense Threat Reduction Agency (DTRA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Defense DEF

Federal funding to support development of biopharmaceutical products to treat military and civilian populations

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
MELISSA DUPREE —
WENDY SHELTON —
JEFFREY STUART WIENER —

Contacted: Defense Threat Reduction Agency (DTRA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

Federal funding to support development of biopharmaceutical products to treat military and civilian populations

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
MELISSA DUPREE —
WENDY SHELTON —
JEFFREY STUART WIENER —

Contacted: Defense Threat Reduction Agency (DTRA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.